
截至10月15日收盘,重组蛋白概念上涨2.66%,位居概念板块涨幅第7,板块内,49股上涨,*ST万方涨停,赛升药业、可孚医疗、热景生物等涨幅居前,分别上涨9.16%、7.86%、6.96%。跌幅居前的有ST未名、洁雅股份、西陇科学等,分别下跌1.74%、1.68%、1.08%。
今日涨跌幅居前的概念板块
概念今日涨跌幅(%)概念今日涨跌幅(%)同花顺果指数3.40兵装重组概念-1.88细胞免疫治疗3.18转基因-1.07PEEK材料3.06深圳国企改革-0.78高压快充2.72光刻机-0.73小米汽车2.68玉米-0.54汽车热管理2.67大豆-0.47重组蛋白2.66光刻胶-0.37减速器2.61稀土永磁-0.24换电概念2.58航运概念-0.20CRO概念2.56中船系-0.16资金面上看,今日重组蛋白概念板块获主力资金净流入3.89亿元,其中,37股获主力资金净流入,6股主力资金净流入超3000万元,净流入资金居首的是通化东宝,今日主力资金净流入4894.36万元,净流入资金居前的还有贝达药业、海特生物、可孚医疗等,主力资金分别净流入4640.88万元、3556.45万元、3517.87万元。
资金流入比率方面,*ST万方、福瑞达、华北制药等流入比率居前,主力资金净流入率分别为31.91%、13.74%、12.46%。(数据宝)
重组蛋白概念资金流入榜
代码简称今日涨跌幅(%)今日换手率(%) 主力资金流量(万元)主力资金净流入比率(%)600867通化东宝4.552.784894.3610.22300558贝达药业-0.772.124640.889.08300683海特生物5.1310.543556.458.10301087可孚医疗7.863.743517.8711.45300149睿智医药5.975.633151.3210.21688068热景生物6.963.753140.065.31688166博瑞医药4.202.242914.515.63300485赛升药业9.1613.492813.736.30688062迈威生物6.305.812388.874.34002007华兰生物0.980.831316.106.18603707健友股份0.680.761311.9410.38688131皓元医药6.192.371230.163.25688136科兴制药3.952.411224.306.50600812华北制药0.840.941211.4112.46600223福瑞达1.951.071171.5413.74688520神州细胞4.900.96906.663.89688687凯因科技0.933.79855.744.55600420国药现代1.030.85827.096.76301108洁雅股份-1.684.77643.076.08600645中源协和1.982.40593.282.09688336三生国健5.680.92538.381.80000638*ST万方5.081.25537.3431.91600351亚宝药业0.742.04509.105.27688266泽璟制药3.551.19492.321.64600566济川药业0.360.33491.206.37688105诺唯赞1.030.47260.806.12688238和元生物0.381.93247.072.56688363华熙生物1.300.49188.451.47301047义翘神州2.330.73169.572.67000513丽珠集团0.501.13168.120.67301371敷尔佳1.972.03165.904.24688739成大生物0.520.4399.832.04002581ST未名-1.741.4272.191.72688293奥浦迈2.891.5358.330.58603983丸美生物3.090.6949.280.46301166优宁维1.151.3443.851.86688137近岸蛋白1.371.0815.811.08600200*ST苏吴3.034.67-5.33-0.16300122智飞生物1.511.74-9.68-0.02301080百普赛斯5.232.21-53.39-0.34300653正海生物1.580.90-61.07-1.88301290东星医疗0.882.27-155.13-3.66688179阿拉丁0.961.64-289.88-4.28688553汇宇制药5.401.79-342.03-2.68688253英诺特0.302.00-394.59-9.37688222成都先导2.692.02-1329.53-7.23300723一品红5.002.88-1351.83-2.04002584西陇科学-1.086.38-1701.36-6.27000813德展健康1.231.70-1862.08-12.74久联优配提示:文章来自网络,不代表本站观点。